Advanced Life Sciences Financial Statements
Advanced Life Sciences Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Advanced Life Sciences Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.1 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (32.6) | (22.6) | (6.2) |
| Total Net Income ($ mil.) | (32.3) | (20.5) | (6.4) |
| Diluted EPS (Net Income) | (1.12) | (0.78) | -- |
Advanced Life Sciences Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (3.6) | (5.5) | (5.8) |
| Total Net Income ($ mil.) | (3.5) | (5.5) | (5.8) |
| Diluted EPS (Net Income) | (0.09) | (0.17) | (0.21) |
Advanced Life Sciences Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 3.72 | 1.52 |
| Price/Earnings Ratio | -- | 15.63 | 14.97 |
| Price/Book Ratio | 8.84 | 2.69 | 1.45 |
| Price/Cash Flow Ratio | -- | 11.17 | 9.34 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Advanced Life Sciences Financial Ratios
Advanced Life Sciences Competitive Intelligence
| GlaxoSmithKline | Johnson & Johnson | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 45,816.1 | 61,095.0 | 48,418.0 |
| Employees | -- | -- | 86,600 |
| Market Cap ($ mil.) | -- | 182,285.9 | 118,188.0 |
Competitive Landscape
